
Avio Smart Market Stack Initiates Strategic Talks with Mediciti Institute for Advanced Diagnostics Collaboration
Avio Smart Market Stack Limited, formerly Bartronics India Limited, has commenced strategic discussions with the Mediciti Institute of Medical Sciences (MIMS) in Hyderabad. The talks are aimed at exploring collaboration opportunities covering research validation and the adoption of advanced molecular diagnostic technologies as part of ASMS's strategy to scale its Diagnostics & Healthcare business vertical.The meeting brought together leadership teams, researchers, clinicians, and academic experts. During the engagement, Huwel Lifesciences, which is ASMS's strategic molecular diagnostics partner, showcased a portfolio of indigenous diagnostic innovations. The objective of the discussion was to examine how these innovative solutions can improve clinical decision-making, strengthen disease detection, and enhance healthcare outcomes across India.
Huwel Lifesciences presented its comprehensive range of indigenous molecular diagnostic technologies. This portfolio includes solutions for tuberculosis, multidrugresistant tuberculosis (MDR-TB), sepsis, HPV screening, hepatitis, respiratory diseases, antimicrobial resistance (AMR) detection, and environmental surveillance. ASMS highlighted that Huwel operates a fully integrated diagnostics platform that encompasses assay development, reagent manufacturing, instrumentation, software, and data management to ensure scalable and affordable delivery of diagnostic solutions.
The discussions centered on generating real world evidence, clinical validation studies, collaborative research, and potential opportunities for product deployment within Mediciti's healthcare ecosystem. The two organizations also explored pilot programs and product evaluations across select departments.
Mediciti Institute was identified as a key strategic partner due to its strong research infrastructure, academic leadership, clinical expertise, and patient volume, making it capable of supporting scientific collaboration and future innovation initiatives.
Commenting on the engagement, Mr. Vidyasagar Reddy, Managing Director of Avio Smart Market Stack, stated that ASMS is committed to building a scalable Diagnostics & Healthcare business through this partnership with Huwel Lifesciences. He noted that while scientific validation is critical, their focus remains equally on accelerating the real world adoption of these technologies by leading healthcare institutions. The engagement offers opportunities for research and clinical evaluation for Huwel's diagnostic solutions across various healthcare applications.
Dr. Shesheer Kumar, Founder and Director of Huwel Lifesciences, emphasized that the future of healthcare innovation relies on close collaboration between technology developers, clinicians, and research institutions. He added that Mediciti’s strong capabilities make it an ideal partner for advancing scientific validation and evaluating innovative diagnostics in real world settings, supporting better patient outcomes and stronger healthcare systems.
The discussions underline the growing significance of collaborations between academic medical institutions and healthcare innovators. ASMS is actively developing market access channels for advanced diagnostic technologies through partnerships with industry stakeholders, government programs, research organizations, and healthcare institutions to accelerate validation, procurement, and large scale deployment of indigenous solutions in India and international markets.
ASMS Stock Price Movement
As of 12:25 PM, shares of Bartronics India Limited are slipping by 0.97% in live trading, currently valued at ₹7.16. The equity sheds ₹0.07 to strike a 52-week low, with 363,441 shares traded so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.